Use of a regenerative biofunctional collagen biomatrix for treating visceral or parietal defects
Techniques for treating visceral or parietal membrane and tissue defects include the application of a collagen biomatrix to the defect to repair and regenerate a visceral or parietal membrane, for example in patients suffering tissue defects or undergoing visceral or parietal surgical treatment. Such approaches avoid persistent tissue leaks and their consequences such as fluid leaks and air leaks. The use of collagen biomatrix, optionally in conjunction with a fibrin sealant, an anti-adhesive, or both, can minimize tissue leaks or fluid leaks in injured patients suffering tissue defects or subjects undergoing surgery such as visceral or parietal resections and other operations.
1. A method for treating a disorder in a patient characterized by a defect of a visceral or parietal membrane, comprising the step of administering to the defect a biofunctional nonporous multilayered collagen foil biomatrix which directs visceral or parietal cell growth within interstices of the multilayered collagen foil biomatrix, wherein a material comprising a polyethylene glycol that is separate from the biomatrix is applied to the multilayered collagen foil biomatrix on a first surface of the multilayered collagen foil biomatrix that is to face away from the defect to which the biomatrix is administered and not on a second surface of the multilayered collagen foil biomatrix that faces the defect.
2. The method according to claim 1 , wherein the multilayered collagen foil biomatrix forms a substantially liquid tight and air tight layer between the visceral or parietal defect and an adjacent tissue.
3. The method according to claim 1 , wherein the administering step comprises one or more methods selected from the group consisting of:
attaching the multilayered collagen foil biomatrix to the visceral or parietal defect with fibrin sealant, attaching the multilayered collagen foil biomatrix to the visceral or parietal defect with surgical sealant, attaching the multilayered collagen foil biomatrix to the visceral or parietal defect with surgical sutures, utilizing pressure fitting techniques, and utilizing natural adhesion between the multilayered collagen foil biomatrix and the visceral or parietal defect.
4. The method according to claim 3 , wherein the multilayered collagen foil biomatrix is attached to the visceral or parietal defect of the patient using a fibrin sealant.
5. The method according to claim 1 , wherein the biomatrix does not promote adhesions with an adjacent tissue after cell growth within interstices of the multilayered collagen foil biomatrix.
6. The method according to claim 1 , wherein the multilayered collagen foil biomatrix directs cell growth on the outer surface of the multilayered collagen foil biomatrix.
7. The method according to claim 1 , wherein the multilayered collagen foil biomatrix comprises an excipient selected from the group consisting of an antibiotic, a preservative, and a growth factor.
8. The method according to claim 1 , wherein the multilayered collagen foil biomatrix comprises collagen derived from a source selected from the group consisting of a bovine source, a porcine source, an equine source, an ovine source, a primate source, a rodentia source, and a human source.
9. The method according to claim 1 , wherein the multilayered collagen foil biomatrix comprises collagen derived from tendon tissue.
10. The method according to claim 1 , wherein the defect comprises a defect of a pleural membrane, and wherein the biofunctional nonporous multilayered collagen foil biomatrix directs pleural cell growth within interstices of the multilayered collagen foil biomatrix.
11. The method according to claim 1 , wherein the material comprising polyethylene glycol is applied to the multilayered collagen foil biomatrix prior to administering the multilayered collagen foil biomatrix to the defect.
12. The method according to claim 1 , wherein the material comprising polyethylene glycol is applied to the multilayered collagen foil biomatrix subsequent to administering the multilayered collagen foil biomatrix to the defect.
13. The method according to claim 12 , wherein the material comprising polyethylene glycol is also applied to tissue adjacent to the defect to which the multilayered collagen foil biomatrix is administered.
14. A method for regenerating a visceral or parietal membrane in a mammal, comprising contacting a defect in the visceral or parietal membrane with a collagen foil comprising a non-naturally occurring biomatrix of multiple layers of collagen fibrils that are not cross-linked by chemicals or radiation, wherein the biomatrix is substantially nonporous, wherein the biomatrix directs visceral or parietal cell growth within interstices of the multilayered collagen foil biomatrix, and wherein a material comprising polyethylene glycol that is separate from the biomatrix is applied to the multilayered collagen foil biomatrix on a first surface of the multilayered collagen foil biomatrix that is to face away from the defect to which the biomatrix is administered and not on a second surface of the multilayered collagen foil biomatrix that faces the defect.
15. The method according to claim 14 , wherein the multilayered collagen foil biomatrix forms a substantially liquid tight and air tight layer between the visceral or parietal membrane and an adjacent tissue.
16. The method according to claim 14 , wherein the multilayered collagen foil biomatrix is attached to the visceral or parietal defect of the patient using a fibrin sealant.
17. The method according to claim 14 , wherein the biomatrix does not promote adhesions with an adjacent tissue after cell growth within interstices of the multilayered collagen foil biomatrix.
18. The method according to claim 14 , wherein the defect comprises a defect of a pleural membrane, and wherein the biofunctional nonporous multilayered collagen foil biomatrix directs pleural cell growth within interstices of the multilayered collagen foil biomatrix.
19. A method for directed cell in-growth and controlled tissue regeneration of a visceral or parietal membrane to prevent post-surgical or post-traumatic adhesion and fibrosis formation on the surface of a tissue in a mammal, comprising contacting the tissue with a nonporous microscopically multilayered collagen foil biomatrix, wherein the biomatrix directs visceral or parietal cell growth within interstices of the multilayered collagen foil biomatrix, and wherein a material comprising polyethylene glycol that is separate from the biomatrix is applied to the multilayered collagen foil biomatrix on a first surface of the multilayered collagen foil biomatrix that is to face away from the defect to which the biomatrix is administered and not on a second surface of the multilayered collagen foil biomatrix that faces the defect.
20. The method according to claim 19 , wherein the multilayered collagen foil biomatrix forms a substantially liquid tight and air tight layer between a visceral or parietal membrane defect and an adjacent tissue.
21. The method according to claim 19 , wherein the multilayered collagen foil biomatrix is attached to the visceral or parietal membrane defect of the patient using a fibrin sealant.
22. The method according to claim 19 , wherein the biomatrix does not promote adhesions with an adjacent tissue after cell growth within interstices of the multilayered collagen foil biomatrix.
23. The method according to claim 19 , wherein the visceral or parietal membrane comprises a pleural membrane, and wherein the nonporous microscopically multilayered collagen foil biomatrix directs pleural cell growth within interstices of the multilayered collagen foil biomatrix.